Author

Jonathan Robertson

Observed name: Jonathan Robertson (13379247)

Institution: University of Sussex

Observed institutions: University of Sussex, GlaxoSmithKline (United Kingdom), GlaxoSmithKline Research & Development Limited (United Kingdom)

OpenAlex ID: A5113732040

Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor

2015 · Aili L. Lazaar, Lucy Yang, et al. · British Journal of Clinical Pharmacology · 176

Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury

2011 · Praveen Anand, Ravikiran Shenoy, et al. · European Journal of Pain · 174

Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study

2013 · Anthony Cahn, Simon Hodgson, et al. · BMC Pharmacology and Toxicology · 55

Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia

2013 · Emiliangelo Ratti, David J. Carpenter, et al. · SLEEP · 51

Clinical Efficacy and Tolerability of a Novel Selective Corticosteroid in Atopic Dermatitis - Two Randomised Controlled Trials

2015 · Sabine Dölle, Nadine Hielscher, et al. · Skin Pharmacology and Physiology · 13

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GW870086: Two Randomised Studies

2013 · Ann Allen, Philippe Bareille, et al. · Current Drug Therapy · 3

Pharmacokinetics, Safety, and Tolerability Following the Administration of a Single Dose of a Combination Tablet Containing Sumatriptan and Naproxen Sodium in Adolescent Patients With Migraine and in Healthy Adult Volunteers

2012 · Alienor Berges, Jonathan Robertson, et al. · Clinical Pharmacology in Drug Development · 3

α4-Containing GABAAReceptors on DRD2 Neurons of the Nucleus Accumbens Mediate Instrumental Responding for Conditioned Reinforcers and Its Potentiation by Cocaine

2023 · Tom Macpherson, Claire I. Dixon, et al. · eNeuro · 2

Efficacy of a New Selective Steroid (GW870086) in Asthma: An Adaptive, Randomised, Controlled Trial

2013 · Philippe Bareille, Kelly Hardes, et al. · Current Drug Therapy · 2

Works count: 10

Citation count: 479

H-index: 5

I10-index: 5